Table:
begin	end	state
1	11	cytoplasmic
12	33	transmembrane
34	40	non-cytoplasmic
41	65	transmembrane
66	95	cytoplasmic
96	118	transmembrane
119	153	non-cytoplasmic
154	173	transmembrane
174	183	cytoplasmic
184	204	transmembrane
205	224	non-cytoplasmic
225	247	transmembrane
248	257	cytoplasmic
258	284	transmembrane
285	304	non-cytoplasmic
305	328	transmembrane
329	348	cytoplasmic
349	371	transmembrane
372	406	non-cytoplasmic
407	426	transmembrane
427	439	cytoplasmic
440	465	transmembrane
466	467	non-cytoplasmic

Input:
>AO353_05685 FitnessBrowser__pseudo3_N2E3:AO353_05685
MSSDKVSVHGSWASRWVFILAATGSAVGLGSIWKFPYMVGVYGGGAFVLVFLACIALIGV
PVMLAETLIGRRARQSPANALKVLALEAGHSAKWSWGAFAGMITALLILSFYSVVGGWSL
DYIIDMGRGDFQGVTADQVGAYFGGVIADPWRLTLWHTLFMLLSAFVIARGVVAGLERSL
RIMMPLLFVMLVILLGYSLTTGHFMEGVHFMFDFNPDKLLDGLLPAMGHAFFSLSVGVGS
IMIYGAYMPKHSSISGTIVGVALLDTFVSLLAGLALFPIVFAAGLNPSEGPGLMFVSLPF
AFGNVAFGQLMGVVFFVLVAIAAWSSAISLLEPMVAYLVERTNIRRGWVTFWLAFSCWFV
GLGTVFSFNIWKQAKFFVNDGGAFHLYQWGAQNGLDFFGVIDFFTSRIMLPLGGLCFVVF
AGWVMGREAVRDELSMRSPALFALTLFLMRYVAPIGILVVFAAQLWK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server